INS and Alzheimer disease: Elevated glucose levels and disrupted glucose metabolism in diabetes and Alzheimer’s disease(AD) may lead to insulin resistance, oxidative stress, and inflammation, affecting cognitive levels (Wang Y. et al., 2023).